326 related articles for article (PubMed ID: 18649477)
1. Assessing the future of diffuse optical imaging technologies for breast cancer management.
Tromberg BJ; Pogue BW; Paulsen KD; Yodh AG; Boas DA; Cerussi AE
Med Phys; 2008 Jun; 35(6):2443-51. PubMed ID: 18649477
[TBL] [Abstract][Full Text] [Related]
2. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.
Tromberg BJ; Cerussi A; Shah N; Compton M; Durkin A; Hsiang D; Butler J; Mehta R
Breast Cancer Res; 2005; 7(6):279-85. PubMed ID: 16457705
[TBL] [Abstract][Full Text] [Related]
3. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy.
O'Sullivan TD; Leproux A; Chen JH; Bahri S; Matlock A; Roblyer D; McLaren CE; Chen WP; Cerussi AE; Su MY; Tromberg BJ
Breast Cancer Res; 2013 Feb; 15(1):R14. PubMed ID: 23433249
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial.
Poellinger A; Persigehl T; Mahler M; Bahner M; Ponder SL; Diekmann F; Bremer C; Moesta T
Invest Radiol; 2011 Nov; 46(11):697-704. PubMed ID: 21788905
[TBL] [Abstract][Full Text] [Related]
5. Mapping breast cancer blood flow index, composition, and metabolism in a human subject using combined diffuse optical spectroscopic imaging and diffuse correlation spectroscopy.
Yazdi HS; O'Sullivan TD; Leproux A; Hill B; Durkin A; Telep S; Lam J; Yazdi SS; Police AM; Carroll RM; Combs FJ; Strömberg T; Yodh AG; Tromberg BJ
J Biomed Opt; 2017 Apr; 22(4):45003. PubMed ID: 28384703
[TBL] [Abstract][Full Text] [Related]
6. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy.
Cerussi A; Shah N; Hsiang D; Durkin A; Butler J; Tromberg BJ
J Biomed Opt; 2006; 11(4):044005. PubMed ID: 16965162
[TBL] [Abstract][Full Text] [Related]
7. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
[TBL] [Abstract][Full Text] [Related]
8. Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI).
Leproux A; Durkin A; Compton M; Cerussi AE; Gratton E; Tromberg BJ
Breast Cancer Res; 2013; 15(5):R89. PubMed ID: 24066941
[TBL] [Abstract][Full Text] [Related]
9. Sample size and power determination when limited preliminary information is available.
McLaren CE; Chen WP; O'Sullivan TD; Gillen DL; Su MY; Chen JH; Tromberg BJ
BMC Med Res Methodol; 2017 Apr; 17(1):75. PubMed ID: 28446127
[TBL] [Abstract][Full Text] [Related]
10. Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trial.
Leproux A; O'Sullivan TD; Cerussi A; Durkin A; Hill B; Hylton N; Yodh AG; Carp SA; Boas D; Jiang S; Paulsen KD; Pogue B; Roblyer D; Yang W; Tromberg BJ
J Biomed Opt; 2017 Dec; 22(12):121604. PubMed ID: 29389104
[TBL] [Abstract][Full Text] [Related]
11. Review of optical breast imaging and spectroscopy.
Grosenick D; Rinneberg H; Cubeddu R; Taroni P
J Biomed Opt; 2016 Sep; 21(9):091311. PubMed ID: 27403837
[TBL] [Abstract][Full Text] [Related]
12. Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.
Cerussi AE; Tanamai VW; Mehta RS; Hsiang D; Butler J; Tromberg BJ
Acad Radiol; 2010 Aug; 17(8):1031-9. PubMed ID: 20542448
[TBL] [Abstract][Full Text] [Related]
13. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
Tank A; Peterson HM; Pera V; Tabassum S; Leproux A; O'Sullivan T; Jones E; Cabral H; Ko N; Mehta RS; Tromberg BJ; Roblyer D
Breast Cancer Res; 2020 Mar; 22(1):29. PubMed ID: 32169100
[TBL] [Abstract][Full Text] [Related]
14. Multi-modal diffuse optical spectroscopy for high-speed monitoring and wide-area mapping of tissue optical properties and hemodynamics.
Lam J; Hill B; Quang T; Amelard R; Kim S; Yazdi H; Warren R; Cutler K; Tromberg B
J Biomed Opt; 2021 Aug; 26(8):. PubMed ID: 34390234
[TBL] [Abstract][Full Text] [Related]
15. Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.
Cerussi AE; Tanamai VW; Hsiang D; Butler J; Mehta RS; Tromberg BJ
Philos Trans A Math Phys Eng Sci; 2011 Nov; 369(1955):4512-30. PubMed ID: 22006904
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer differential diagnosis using diffuse optical spectroscopic imaging and regression with z-score normalized data.
Cochran JM; Leproux A; Busch DR; O'Sullivan TD; Yang W; Mehta RS; Police AM; Tromberg BJ; Yodh AG
J Biomed Opt; 2021 Feb; 26(2):. PubMed ID: 33624457
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress.
Xu C; Vavadi H; Merkulov A; Li H; Erfanzadeh M; Mostafa A; Gong Y; Salehi H; Tannenbaum S; Zhu Q
Ultrason Imaging; 2016 Jan; 38(1):5-18. PubMed ID: 25887527
[TBL] [Abstract][Full Text] [Related]
18. Time-domain optical mammography SoftScan: initial results.
Intes X
Acad Radiol; 2005 Aug; 12(8):934-47. PubMed ID: 16023382
[TBL] [Abstract][Full Text] [Related]
19. Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.
Choe R; Corlu A; Lee K; Durduran T; Konecky SD; Grosicka-Koptyra M; Arridge SR; Czerniecki BJ; Fraker DL; DeMichele A; Chance B; Rosen MA; Yodh AG
Med Phys; 2005 Apr; 32(4):1128-39. PubMed ID: 15895597
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
